Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

1(14%)

Results Posted

0%(0 trials)

Terminated

1(14%)

Phase Distribution

Ph not_applicable

29%

Ph phase_4

43%

Ph phase_1

14%

Ph phase_2

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

1(14.3%)

Phase 2Efficacy & side effects

1(14.3%)

Phase 4Post-market surveillance

3(42.9%)

N/ANon-phased studies

2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Terminated(1)

Other(3)

Detailed Status

unknown3

Completed2

Terminated1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (14.3%)

Phase 21 (14.3%)

Phase 43 (42.9%)

N/A2 (28.6%)

Trials by Status

terminated114%

recruiting114%

unknown343%

completed229%

Recent Activity

1 active trials

Showing 5 of 7

recruitingphase_1

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

NCT06126731

terminatedphase_4

Oral Penicillin Challenge and Allergy De-labeling in Children

NCT05563610

unknownnot_applicable

Biofunctionalization of a Volume-stable Collagen Matrix (VCMX) for the Treatment of Single Gingival Recession

NCT05916742

unknownnot_applicable

Use of a Novel Volume-stable Collagen Matrix (VCMX) in the Treatment of Single Gingival Recession Associated With Non-carious Cervical Lesion Partially Restored

NCT05916716

unknownphase_4

Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome

NCT04580355

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT06126731Phase 1

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Recruiting

NCT05563610Phase 4

Oral Penicillin Challenge and Allergy De-labeling in Children

Terminated

NCT05916742Not Applicable

Biofunctionalization of a Volume-stable Collagen Matrix (VCMX) for the Treatment of Single Gingival Recession

Unknown

NCT05916716Not Applicable

Use of a Novel Volume-stable Collagen Matrix (VCMX) in the Treatment of Single Gingival Recession Associated With Non-carious Cervical Lesion Partially Restored

Unknown

NCT04580355Phase 4

Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome

Unknown

NCT04132479Phase 4

The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar

Completed

NCT03132714Phase 2

Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7